Today: 7 February 2026
Subscribe
Browse Category

Financial News News 21 January 2026

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

Corvus Pharmaceuticals shares fell 8% to $19.68 in premarket trading Wednesday after announcing a $150 million stock-and-warrant offering. The drop follows a 167% surge Tuesday on positive Phase 1 data for soquelitinib in atopic dermatitis. Corvus paused its $100 million at-the-market share sales facility ahead of the new deal. No severe adverse events were reported in the trial.
21 January 2026
·····
HYMC stock pops in premarket: what’s driving Hycroft Mining as gold tops $4,800

HYMC stock pops in premarket: what’s driving Hycroft Mining as gold tops $4,800

Hycroft Mining shares surged 24% to $42.77 in Wednesday’s premarket as gold hit a record above $4,800 an ounce amid U.S.-NATO tensions over Greenland. A Form 144 filing showed a trust linked to a Hycroft director plans a minor share sale. Silver hovered just below its all-time high. Other miners also advanced, with Newmont up 4% and Hecla Mining rising 6%.
21 January 2026
·····
Block stock steadies before the bell after 5% slide as $200B lending milestone hits tape

Block stock steadies before the bell after 5% slide as $200B lending milestone hits tape

Block Inc shares rose 0.3% to $62.82 premarket Wednesday after sliding 5% the previous day amid a broad U.S. market selloff. The company said it has extended over $200 billion in credit through Cash App Borrow, Afterpay, and Square Loans, maintaining steady loss rates since 2013. Block’s quarterly earnings are due Feb. 19. Investors are watching for signs of credit stress as lending volumes grow.
21 January 2026
···
Peloton stock price ahead of the open: PTON steadies after 7% slide as insider sale filing lands

Peloton stock price ahead of the open: PTON steadies after 7% slide as insider sale filing lands

Peloton shares hovered near $5.86 in early premarket Wednesday after a 7.4% drop Tuesday and heavy trading volume. A regulatory filing showed COO Charles Kirol sold 22,520 shares on Jan. 16 to cover taxes on vested stock awards. Investors await the Feb. 5 quarterly report for signs of stabilizing subscription numbers. Revenue and paid subscriptions both fell 6% year-on-year in the last quarter.
21 January 2026
····
United Airlines stock pops in premarket after UAL lifts 2026 profit outlook — what investors watch next

United Airlines stock pops in premarket after UAL lifts 2026 profit outlook — what investors watch next

United Airlines shares rose about 4% to $113.02 in premarket trading Wednesday after the company raised its 2026 profit forecast, citing strong premium and loyalty revenue. Fourth-quarter adjusted earnings reached $3.10 per share on $15.4 billion revenue. The airline estimated a $250 million pre-tax hit from the U.S. government shutdown. Management’s earnings call is scheduled for later Wednesday.
21 January 2026
····
Experian share price slides 5% after Q3 trading update keeps outlook unchanged — what to watch next

Experian share price slides 5% after Q3 trading update keeps outlook unchanged — what to watch next

Experian shares fell 5.3% to 3,055 pence in early London trading Wednesday after its third-quarter update, despite reporting 8% organic revenue growth and maintaining its full-year outlook. The stock touched a 52-week low of 3,032 pence. Investors are watching U.S. lending and mortgage trends for signs of momentum shifts.
21 January 2026
·····
GSK stock slips after $2.2 billion RAPT deal — what investors watch before the open

GSK stock slips after $2.2 billion RAPT deal — what investors watch before the open

GSK’s U.S.-listed shares fell 1.2% to $47.65 premarket after it agreed to buy RAPT Therapeutics for $2.2 billion, paying a 65% premium for rights to a mid-stage food allergy drug. The deal, led by new CEO Luke Miels, comes as GSK faces pressure to offset losses from expiring HIV drug patents. Pfizer will exit the ViiV Healthcare joint venture, with Shionogi raising its stake to 21.7%.
21 January 2026
·····
London Stock Exchange Group (LSEG) share price drops as buyback update lands and tariff jitters linger

London Stock Exchange Group (LSEG) share price drops as buyback update lands and tariff jitters linger

London Stock Exchange Group shares fell 1.8% to 8,820 pence in early trading Wednesday, hitting a session low of 8,794 pence. The company disclosed a new tranche of share buybacks after purchasing 110,386 shares on January 19. Investors remain cautious ahead of LSEG’s February 26 results and possible U.S. tariffs on UK assets.
21 January 2026
····
HSBC share price slips in London as trade jitters weigh on banks, UK inflation in focus

HSBC share price slips in London as trade jitters weigh on banks, UK inflation in focus

HSBC shares fell 0.8% to 1,221 pence in early London trading, tracking declines across European banks after renewed U.S.-Europe trade tensions. The STOXX 600 slipped 0.1% and the Europe-wide banks index dropped 0.6%. UK inflation rose to 3.4% in December, adding pressure on rate forecasts. HSBC also announced a pilot with Harvey AI for its Global Legal division.
21 January 2026
······
National Grid share price ticks up after Massachusetts rate-case filing as UK inflation resets the mood

National Grid share price ticks up after Massachusetts rate-case filing as UK inflation resets the mood

National Grid shares rose 0.2% to 1,192.5 pence in early London trading after a U.S. unit sought a $144 million revenue increase and a 10.25% return on equity. UK inflation climbed to 3.4% in December, above forecasts, narrowing prospects for rate cuts. Chief people officer Will Serle sold 21,800 shares for about £263,000.
21 January 2026
·····
1 … 152 153 154 155 156 … 750

Stock Market Today

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

7 February 2026
London, Feb 7, 2026, 08:20 GMT — Market closed. London Stock Exchange Group plc (LSEG.L) shares ended Friday at 7,502 pence, down about 1.1% on the day, with London markets shut for the weekend and set to reopen on Monday. (MarketWatch) The stock has been caught in a wider repricing of software, data and analytics names as investors question which business models benefit from the next wave of AI — and which get squeezed. “It’s a de-risking trade,” Andrew Wells, chief investment officer at SanJac Alpha, said, as he argued the AI build-out had become “too pricey.” (Reuters) LSEG also
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop